Product Information
GENVOYA TABLET is a brand product labeled by Gilead Sciences, Inc., priced at $143.3497 per EA under NDC 61958190101. Its NADAC has been published 541 times since Feb 17, 2016.
Strength
150; 150; 200; 10 mg/1; mg/1; mg/1; mg/1
Manufacturer
Gilead Sciences, Inc.NDC
61958190101
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATEApproval Type
New Drug (NDA)
FDA Application
NDA207561On Market Since
11/5/2015
Pharmacological Classes
Price Statistics
The NADAC for GENVOYA TABLET has been published 541 times since Feb 17, 2016, and over the history we have for it it has risen 71.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $143.3497 per EA |
|---|---|
| All-time high | $143.3501 (May 13, 2026) |
| All-time low | $82.7351 (Jan 18, 2017) |
| 52-week high | $143.3501 |
| 52-week low | $136.5247 |
| Median price | $109.9641 |
| Average price | $110.2756 |
| Largest weekly change | +6.9% (Feb 15, 2017) |
| Weeks tracked | 541 |
| Tracking since | Feb 17, 2016 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of GENVOYA TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GENVOYA TABLET, manufactured by Gilead Sciences, Inc., is $143.3497 per EA (NDC 61958190101), effective Jun 24, 2026.
How has the price of GENVOYA TABLET changed over time?
Over the history we have for it, the NADAC for GENVOYA TABLET has risen 71.5%. It has been tracked across 541 weekly CMS publications since Feb 17, 2016.
What are the highest and lowest recorded NADAC prices for GENVOYA TABLET?
Since Feb 17, 2016, the NADAC for GENVOYA TABLET has ranged from a low of $82.7351 (Jan 18, 2017) to a high of $143.3501 (May 13, 2026), with a median of $109.9641 per EA.
Are there cheaper alternatives to GENVOYA TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of GENVOYA TABLET, so no direct lower-cost alternative is listed.
Who manufactures GENVOYA TABLET?
GENVOYA TABLET (NDC 61958190101) is labeled by Gilead Sciences, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification